MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses.
A prevailing neuroinflammation hypothesis is that increased production of proinflammatory cytokines contributes to progressive neuropathology, secondary to the primary damage caused by a traumatic brain injury (TBI). In support of the hypothesis, post-injury interventions that inhibit the proinflamm...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0149451 |
id |
doaj-32ab32dac3e442338effa09f838c073e |
---|---|
record_format |
Article |
spelling |
doaj-32ab32dac3e442338effa09f838c073e2021-03-04T11:33:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01112e014945110.1371/journal.pone.0149451MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses.Adam D BachstetterZhengqiu ZhouRachel K RoweBin XingDanielle S GouldingAlyssa N ConleyPradoldej SompolShelby MeierJose F AbisambraJonathan LifshitzD Martin WattersonLinda J Van EldikA prevailing neuroinflammation hypothesis is that increased production of proinflammatory cytokines contributes to progressive neuropathology, secondary to the primary damage caused by a traumatic brain injury (TBI). In support of the hypothesis, post-injury interventions that inhibit the proinflammatory cytokine surge can attenuate the progressive pathology. However, other post-injury neuroinflammatory responses are key to endogenous recovery responses. Therefore, it is critical that pharmacological attenuation of detrimental or dysregulated neuroinflammatory processes avoid pan-suppression of inflammation. MW151 is a CNS-penetrant, small molecule experimental therapeutic that restores injury- or disease-induced overproduction of proinflammatory cytokines towards homeostasis without immunosuppression. Post-injury administration of MW151 in a closed head injury model of mild TBI suppressed acute cytokine up-regulation and downstream cognitive impairment. Here, we report results from a diffuse brain injury model in mice using midline fluid percussion. Low dose (0.5-5.0 mg/kg) administration of MW151 suppresses interleukin-1 beta (IL-1β) levels in the cortex while sparing reactive microglia and astrocyte responses. To probe molecular mechanisms, we used live cell imaging of the BV-2 microglia cell line to demonstrate that MW151 does not affect proliferation, migration, or phagocytosis of the cells. Our results provide insight into the roles of glial responses to brain injury and indicate the feasibility of using appropriate dosing for selective therapeutic modulation of injurious IL-1β increases while sparing other glial responses to injury.https://doi.org/10.1371/journal.pone.0149451 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Adam D Bachstetter Zhengqiu Zhou Rachel K Rowe Bin Xing Danielle S Goulding Alyssa N Conley Pradoldej Sompol Shelby Meier Jose F Abisambra Jonathan Lifshitz D Martin Watterson Linda J Van Eldik |
spellingShingle |
Adam D Bachstetter Zhengqiu Zhou Rachel K Rowe Bin Xing Danielle S Goulding Alyssa N Conley Pradoldej Sompol Shelby Meier Jose F Abisambra Jonathan Lifshitz D Martin Watterson Linda J Van Eldik MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses. PLoS ONE |
author_facet |
Adam D Bachstetter Zhengqiu Zhou Rachel K Rowe Bin Xing Danielle S Goulding Alyssa N Conley Pradoldej Sompol Shelby Meier Jose F Abisambra Jonathan Lifshitz D Martin Watterson Linda J Van Eldik |
author_sort |
Adam D Bachstetter |
title |
MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses. |
title_short |
MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses. |
title_full |
MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses. |
title_fullStr |
MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses. |
title_full_unstemmed |
MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses. |
title_sort |
mw151 inhibited il-1β levels after traumatic brain injury with no effect on microglia physiological responses. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2016-01-01 |
description |
A prevailing neuroinflammation hypothesis is that increased production of proinflammatory cytokines contributes to progressive neuropathology, secondary to the primary damage caused by a traumatic brain injury (TBI). In support of the hypothesis, post-injury interventions that inhibit the proinflammatory cytokine surge can attenuate the progressive pathology. However, other post-injury neuroinflammatory responses are key to endogenous recovery responses. Therefore, it is critical that pharmacological attenuation of detrimental or dysregulated neuroinflammatory processes avoid pan-suppression of inflammation. MW151 is a CNS-penetrant, small molecule experimental therapeutic that restores injury- or disease-induced overproduction of proinflammatory cytokines towards homeostasis without immunosuppression. Post-injury administration of MW151 in a closed head injury model of mild TBI suppressed acute cytokine up-regulation and downstream cognitive impairment. Here, we report results from a diffuse brain injury model in mice using midline fluid percussion. Low dose (0.5-5.0 mg/kg) administration of MW151 suppresses interleukin-1 beta (IL-1β) levels in the cortex while sparing reactive microglia and astrocyte responses. To probe molecular mechanisms, we used live cell imaging of the BV-2 microglia cell line to demonstrate that MW151 does not affect proliferation, migration, or phagocytosis of the cells. Our results provide insight into the roles of glial responses to brain injury and indicate the feasibility of using appropriate dosing for selective therapeutic modulation of injurious IL-1β increases while sparing other glial responses to injury. |
url |
https://doi.org/10.1371/journal.pone.0149451 |
work_keys_str_mv |
AT adamdbachstetter mw151inhibitedil1blevelsaftertraumaticbraininjurywithnoeffectonmicrogliaphysiologicalresponses AT zhengqiuzhou mw151inhibitedil1blevelsaftertraumaticbraininjurywithnoeffectonmicrogliaphysiologicalresponses AT rachelkrowe mw151inhibitedil1blevelsaftertraumaticbraininjurywithnoeffectonmicrogliaphysiologicalresponses AT binxing mw151inhibitedil1blevelsaftertraumaticbraininjurywithnoeffectonmicrogliaphysiologicalresponses AT daniellesgoulding mw151inhibitedil1blevelsaftertraumaticbraininjurywithnoeffectonmicrogliaphysiologicalresponses AT alyssanconley mw151inhibitedil1blevelsaftertraumaticbraininjurywithnoeffectonmicrogliaphysiologicalresponses AT pradoldejsompol mw151inhibitedil1blevelsaftertraumaticbraininjurywithnoeffectonmicrogliaphysiologicalresponses AT shelbymeier mw151inhibitedil1blevelsaftertraumaticbraininjurywithnoeffectonmicrogliaphysiologicalresponses AT josefabisambra mw151inhibitedil1blevelsaftertraumaticbraininjurywithnoeffectonmicrogliaphysiologicalresponses AT jonathanlifshitz mw151inhibitedil1blevelsaftertraumaticbraininjurywithnoeffectonmicrogliaphysiologicalresponses AT dmartinwatterson mw151inhibitedil1blevelsaftertraumaticbraininjurywithnoeffectonmicrogliaphysiologicalresponses AT lindajvaneldik mw151inhibitedil1blevelsaftertraumaticbraininjurywithnoeffectonmicrogliaphysiologicalresponses |
_version_ |
1714803533790838784 |